Covered recipient · General Payments record
LILLIAM PEREZ RODRIGUEZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,661.19
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,137.87 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $617.28 | 7 |
| Amgen Inc. | $341.21 | 8 |
| ABBVIE INC. | $125.37 | 1 |
| Novo Nordisk AS | $34.24 | 2 |
| Lilly USA, LLC | $19.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.37 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107834694 | CMS |
| Amgen Inc. | $11.51 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117653496 | CMS |
| Amgen Inc. | $91.57 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117653506 | CMS |
| Amgen Inc. | $91.57 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117653508 | CMS |
| Amgen Inc. | $90.34 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117351635 | CMS |
| Amgen Inc. | $11.71 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117653498 | CMS |
| Amgen Inc. | $1.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117653500 | CMS |
| Amgen Inc. | $16.88 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117653502 | CMS |
| Amgen Inc. | $26.63 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117653504 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.97 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104714927 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.96 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104693494 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.59 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104358705 | CMS |
| AstraZeneca Pharmaceuticals LP | $119.92 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105726009 | CMS |
| AstraZeneca Pharmaceuticals LP | $119.92 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105446711 | CMS |
| AstraZeneca Pharmaceuticals LP | $90.73 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105700850 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.19 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105657814 | CMS |
| Lilly USA, LLC | $19.77 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135799182 | CMS |
| Novo Nordisk Inc | $16.06 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100501385 | CMS |
| Novo Nordisk Inc | $18.18 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100370429 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.